InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Krognes Steve E., Chief Financial Officer. Insider active across 2 companies, notably Denali Therapeutics Inc.. In total, 60 disclosures have been recorded. Split: 0 buy · 17 sells. Total volume traded: €3.9m. Activity tracked since 19 August 2021. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Krognes Steve E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
6,408 shares0Common StockSEC:0001666236-26-000015:0
154 shares0Common StockSEC:0001666236-26-000011:0
155 shares0Common StockSEC:0001666236-26-000009:0
154 shares0Common StockSEC:0001666236-26-000006:0
154 shares0Common StockSEC:0001666236-26-000004:0
154 shares0Common StockSEC:0001666236-26-000002:0
155 shares0Common StockSEC:0001666236-25-000013:0
154 shares0Common StockSEC:0001666236-25-000011:0
154 shares0Common StockSEC:0001666236-25-000009:0
155 shares0Common StockSEC:0001666236-25-000007:0
154 shares0Common StockSEC:0001576280-25-000248:0
154 shares0Common StockSEC:0001576280-25-000211:0
6,674 shares0Common StockSEC:0001576280-25-000175:0
6,037 shares0Common StockSEC:0001714899-25-000139:0
154 shares0Common StockSEC:0001576280-25-000155:0
155 shares0Common StockSEC:0001576280-25-000138:0
154 shares0Common StockSEC:0001576280-25-000108:0
154 shares0Common StockSEC:0001576280-25-000048:0
154 shares0Common StockSEC:0001576280-25-000032:0
3,339 shares@ US$20.811.6% of flowCommon StockSEC:0001714899-25-000048:0
30,000 shares@ US$20.2513.9% of flowCommon StockSEC:0001714899-25-000002:0
155 shares0Common StockSEC:0001576280-25-000002:0
154 shares0Common StockSEC:0001576280-24-000289:0
154 shares0Common StockSEC:0001576280-24-000253:0
30,000 shares@ US$29.0318.7% of flowCommon StockSEC:0001714899-24-000200:0
25 of 60 declarations
About Krognes Steve E.
Krognes Steve E. is Director Financier and has 60 filings in total. Among the recent filings available, they cover the period from 2021-08-23 to 2026-06-05, with 0 in buys and 3929871 in sells, mainly as Levée d'options, at Denali Therapeutics Inc. and Guardant Health, Inc.
